Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Orchard Therapeutics Plc ADR (ORTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,312,021
  • Shares Outstanding, K 84,047
  • Annual Sales, $ 0 K
  • Annual Income, $ -39,740 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.49
  • Number of Estimates 1
  • High Estimate -0.49
  • Low Estimate -0.49
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.75 +32.85%
on 01/22/19
17.97 -13.13%
on 02/20/19
+2.29 (+17.19%)
since 01/18/19
3-Month
8.65 +80.46%
on 12/21/18
17.97 -13.13%
on 02/20/19
-0.43 (-2.68%)
since 11/21/18

Most Recent Stories

More News
Orchard Therapeutics Announces Acceptance of Late-Breaking Abstracts of OTL-101 for ADA-SCID and OTL-102 for X-CGD at the 2019 Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR

Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative...

ORTX : 15.61 (-2.25%)
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine

Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative...

ORTX : 15.61 (-2.25%)
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy

Preparing Three Lead Programs for MLD, ADA-SCID and WAS for Regulatory Filings Over the Next Three Years

ORTX : 15.61 (-2.25%)
Orchard Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019

BOSTON and LONDON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious...

ORTX : 15.61 (-2.25%)
JPM : 105.47 (-0.21%)
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

New facility expected to create more than 100 new jobs, supporting extensive gene therapy pipeline

ORTX : 15.61 (-2.25%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 23.41 (-1.06%)
NGVC : 14.36 (-1.71%)
STC : 42.39 (-0.93%)
ATUS : 21.03 (-0.85%)
RBA : 36.52 (-0.19%)
MHK : 140.03 (+0.19%)
NVCR : 53.38 (+0.32%)
CVSI : 4.8305 (-2.41%)
AC : 41.73 (-0.26%)
BSX : 40.12 (+0.02%)
HON : 152.61 (-1.27%)
POTND : 0.0200 (+32.45%)
PRTT : 1.0000 (-20.00%)
TARSD : 0.2033 (-1.64%)
NKE : 83.95 (-1.05%)
ROIC : 17.25 (-0.06%)
DGX : 87.81 (-1.27%)
EIX : 61.26 (-2.27%)
GARLF : 0.0794 (-3.99%)
MRNA : 19.34 (-2.91%)
MSPC : 0.0002 (unch)
RYAAY : 73.36 (+0.22%)
BA : 417.58 (-0.94%)
BDC : 60.34 (-5.38%)
BC : 52.10 (-0.36%)
OXFD : 16.87 (-2.60%)
NDAQ : 88.07 (-0.01%)
TTOO : 3.72 (+0.27%)
DMAC : 3.52 (-2.76%)
CMCM : 7.18 (+0.14%)
ALGN : 250.23 (-1.40%)
ABM : 36.68 (-0.11%)
RTN : 185.38 (-1.02%)
IESC : 18.99 (+1.55%)
KIDS : 38.34 (+0.71%)
CYL.VN : 0.165 (+3.13%)
FLIR : 52.25 (-1.04%)
NETC.CN : 0.110 (+4.76%)
SLCA : 15.32 (-3.95%)
BANX : 21.25 (+0.85%)
APOG : 37.10 (+0.41%)
RBBN : 5.36 (-11.70%)
SPLIF : 0.2240 (+0.86%)
SO : 50.22 (+0.97%)
SNWV : 0.1744 (+2.71%)
ACB : 7.06 (-0.14%)
CE : 102.50 (-0.21%)
QILFF : 0.1850 (+1.04%)
QILFD : 0.2331 (-29.98%)
MANH : 54.04 (-0.93%)
MKL : 1,010.40 (-0.92%)
HAL : 31.38 (-2.82%)
LZB : 35.79 (-0.61%)
INTC : 51.41 (+0.04%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,619.44 (-0.16%)
ACHC : 27.72 (+0.65%)
TX : 29.85 (+0.88%)
SRPT : 136.54 (-2.87%)
JOUT : 66.87 (+1.89%)
CCAN : 0.2500 (-3.47%)
OBMP : 0.0100 (+4.17%)
ELY : 16.91 (-0.88%)
DY : 62.62 (-1.65%)
HIPH : 0.0535 (+0.19%)
POTN : 0.1598 (-6.33%)
JWN : 44.49 (-1.13%)
SYF : 31.78 (-0.03%)
AQUA : 12.90 (-1.07%)
NWVCF : 1.2700 (-1.50%)
USYNF : 2.5745 (-18.27%)
EMR : 67.74 (-1.22%)
BXE : 0.46 (-3.16%)
HSY : 111.20 (+0.47%)
EW : 173.94 (-1.55%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 14.40 (+1.05%)
PSX : 96.81 (-0.66%)
MVIS : 1.18 (+2.61%)
PCI : 22.97 (+0.13%)
PCN : 16.47 (+0.49%)
AVT : 44.75 (-0.40%)
MGNX : 21.88 (-1.57%)
ICBK : 19.10 (+0.53%)
DLR : 116.37 (-1.79%)
RHI : 67.39 (-0.50%)
YVR : 2.26 (+7.11%)
PTY : 16.80 (+0.18%)
PDI : 31.26 (+0.19%)
TNXP : 1.96 (unch)
GBT : 50.00 (-1.09%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 85.84 (-0.38%)
NKTR : 40.26 (-6.44%)
GOOG : 1,096.97 (-1.51%)
JBLU : 17.49 (-0.40%)
IGC : 2.49 (unch)
WBT : 15.85 (-1.37%)
WRY.VN : 0.100 (+66.67%)
SAPIF : 31.5581 (+1.42%)
WSO : 142.92 (-0.11%)
LMT : 304.51 (-0.88%)
CMCSA : 38.47 (+1.80%)
HSDT : 7.40 (+0.14%)
GWRE : 91.04 (-0.68%)
CLGX : 39.89 (-0.35%)
FNSR : 23.93 (-0.04%)
SONS : 7.83 (+2.76%)
DEWM : 0.0011 (unch)
SLG : 91.49 (+0.68%)
UPS : 111.76 (+0.62%)
PFN : 10.21 (-0.68%)
KMB : 119.73 (+0.97%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.09 (-0.91%)
NSU : 4.53 (-0.22%)
CBDS : 3.1400 (-1.57%)
CTXS : 104.99 (-0.36%)
PCOM : 10.89 (+0.65%)
HTHT : 34.34 (-2.94%)
MAN : 84.61 (+0.08%)
CNK : 36.90 (-0.70%)
AMAT : 38.83 (-0.44%)
FMCC : 2.7700 (+0.36%)
MRK : 79.83 (+0.50%)
ATOS : 1.44 (-4.64%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0680 (+1.95%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 57.80 (-0.81%)
COOL : 17.33 (-0.69%)
SAVE : 59.58 (+2.71%)
PCRX : 39.61 (-1.59%)
RNLSY : 13.5050 (-0.55%)
COL : 141.04 (-0.42%)
COR : 104.35 (-1.34%)
IDXG : 0.95 (unch)
MCD : 182.81 (+1.29%)
ETST : 0.6730 (-3.86%)
QNIIF : 0.7100 (-2.62%)
PII : 85.95 (-1.06%)
AMRS : 4.63 (+3.58%)
SON : 59.59 (-1.26%)
MCK : 131.95 (-1.56%)
APHA : 10.38 (+2.27%)
MCO : 170.60 (+0.67%)
GSKY : 10.37 (-1.05%)
LH : 148.32 (-0.95%)
SAP.TO : 41.64 (-0.29%)
ODFL : 152.00 (-0.33%)
NEU : 440.71 (+0.90%)
ORTX : 15.61 (-2.25%)
BXE.TO : 0.59 (-4.84%)
GWPRF : 11.7000 (-3.31%)
PZN : 9.70 (+3.41%)
RBX.VN : 0.075 (+7.14%)
RNG : 104.09 (+0.18%)
SPG : 182.15 (+1.63%)
TRVN : 1.39 (-2.11%)
AMC : 13.70 (+0.22%)
UTX : 126.32 (-1.64%)
AMD : 23.92 (-0.13%)
NDLS : 7.45 (+0.95%)
MPWR : 135.29 (-1.00%)
KGKG : 0.0799 (-1.36%)
FRO-UN.VN : 0.520 (-5.45%)
DMCAF : 0.3840 (+0.52%)
IRMTF : 11.9721 (-0.40%)
BOX : 24.29 (+0.54%)
IQST : 2.3800 (+90.40%)
ASPS : 24.09 (-1.03%)
HMNY : 0.0082 (+17.14%)
ROP : 314.80 (+0.42%)
GOVB : 14.0500 (-10.79%)
PKO : 26.18 (-0.04%)
MYGN : 31.70 (-0.88%)
CRL : 142.39 (+0.51%)
GLPH : 0.0151 (-22.16%)
BXXRF : 0.0102 (+100.00%)
ADTN : 14.54 (-0.27%)
GRNH : 0.0187 (+1.63%)
NS : 26.19 (-0.91%)
LTS : 2.99 (-0.99%)
INT : 26.23 (+0.27%)
INPX : 1.45 (-3.33%)
GSPT : 0.0400 (unch)
MRO.VN : 0.090 (unch)
COST : 215.23 (-0.87%)
EFX : 110.49 (+2.18%)
BMRN : 88.81 (-2.04%)
SPGI : 198.15 (+0.07%)
IGCC : 0.3800 (+1.33%)
PYPL : 94.96 (+0.24%)
LHSIF : 0.8840 (+4.68%)
TDY : 233.29 (-1.08%)
AZPN : 99.64 (-0.12%)
ENW.VN : 1.680 (+1.20%)
DMA.VN : 4.630 (-2.11%)
SNAP : 9.39 (+1.62%)
KSU : 111.75 (+0.62%)
MERC : 14.72 (-3.29%)
DVA : 59.21 (+0.25%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.48 (-0.80%)
IGAP : 0.4900 (-19.67%)
FIT : 6.63 (-0.15%)
RAD : 0.75 (-2.60%)
LDSR : 0.0029 (+7.41%)
CYLYF : 0.1253 (+9.05%)
PMX : 12.00 (+0.17%)
ROBXF : 0.1851 (+262.94%)
BRO : 29.44 (unch)
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting

First demonstration of potential gene therapy treatment in this population leading to sustained levels of functioning neutrophils after 12 months

ORTX : 15.61 (-2.25%)
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations

Commercial team preparing for potential gene therapy launches

ORTX : 15.61 (-2.25%)
Orchard Therapeutics Announces Pricing of Initial Public Offering

Orchard Therapeutics plc (Nasdaq: ORTX), a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies,...

ORTX : 15.61 (-2.25%)
JPM : 105.47 (-0.21%)
Trade ORTX with:

Business Summary

Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based...

See More

Key Turning Points

2nd Resistance Point 16.66
1st Resistance Point 16.13
Last Price 15.61
1st Support Level 15.24
2nd Support Level 14.88

See More

52-Week High 19.24
Last Price 15.61
Fibonacci 61.8% 15.19
Fibonacci 50% 13.94
Fibonacci 38.2% 12.70
52-Week Low 8.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar